Wordt geladen...
Long‐term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2‐year study
OBJECTIVE: To evaluate the long‐term clinical and exercise effect of chronic oral administration of the non‐selective endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension (PAH) related to congenital heart disease (CHD). DESIGN: Extension of a preceding prospective...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Group
2007
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1861451/ https://ncbi.nlm.nih.gov/pubmed/16980516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.100388 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|